These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. Guha IN; Rosenberg WM Clin Liver Dis; 2008 Nov; 12(4):883-900, x. PubMed ID: 18984472 [TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of hepatic fibrosis and cirrhosis]. Arends JE; de Knegt RJ; van Erpecum KJ; Hoepelman IM Ned Tijdschr Geneeskd; 2007 Jul; 151(27):1502-6. PubMed ID: 17763808 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice. Duarte-Rojo A; Altamirano JT; Feld JJ Ann Hepatol; 2012; 11(4):426-39. PubMed ID: 22700624 [TBL] [Abstract][Full Text] [Related]
6. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941 [TBL] [Abstract][Full Text] [Related]
7. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis. Golabi P; Sayiner M; Fazel Y; Koenig A; Henry L; Younossi ZM Expert Rev Gastroenterol Hepatol; 2016; 10(1):63-71. PubMed ID: 26469309 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Rockey DC Gastroenterology; 2008 Jan; 134(1):8-14. PubMed ID: 18166342 [TBL] [Abstract][Full Text] [Related]
14. Non-invasive diagnosis of advanced fibrosis and cirrhosis. Sharma S; Khalili K; Nguyen GC World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996 [TBL] [Abstract][Full Text] [Related]
15. Serum laboratory markers for noninvasive diagnosis and monitoring of liver fibrogenesis in patients with chronic liver diseases. Vozar I Bratisl Lek Listy; 2005; 106(3):123-6. PubMed ID: 16026147 [TBL] [Abstract][Full Text] [Related]
16. Assessment of fibrosis and cirrhosis in liver biopsies: an update. Germani G; Hytiroglou P; Fotiadu A; Burroughs AK; Dhillon AP Semin Liver Dis; 2011 Feb; 31(1):82-90. PubMed ID: 21344353 [TBL] [Abstract][Full Text] [Related]
17. [A clinical study on combined serum hepatic fibrosis-related markers and ultrasound parameters to diagnose hepatic fibrosis]. Yu J; Jia CH; Wang Q; Xu PS; Zhang H; Zhao YQ; Shen Q; Hao YR; Cai GF Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):56-8. PubMed ID: 17429537 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of fibrosis and steatosis in NASH and ASH. Angulo P Gastroenterol Clin Biol; 2009; 33(10-11):940-8. PubMed ID: 19800187 [TBL] [Abstract][Full Text] [Related]
19. [Clinical application of non-invasive diagnosis for hepatic fibrosis]. Cho SW; Cheong JY Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186 [TBL] [Abstract][Full Text] [Related]
20. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Carrión JA; Navasa M; Bosch J; Bruguera M; Gilabert R; Forns X Liver Transpl; 2006 Dec; 12(12):1791-8. PubMed ID: 16823833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]